2+ influx into a presynaptic terminal triggers fusion of neurotransmitter-filled synaptic vesicles with the presynaptic plasma membrane 1,2 . The SNARE proteins synaptobrevin-2/VAMP2 on the synaptic vesicle and syntaxin-1A and SNAP-25 on the plasma membrane initiate vesicle fusion by forming a trans-SNARE complex before Ca 2+ triggering 3,4 . In addition to SNAREs, synaptotagmin-1 (Syt1) is vital for Ca 2+ -triggered synaptic vesicle fusion 5, 6 . Syt1 contains a single transmembrane-spanning domain and two C-terminal cytoplasmic C2 domains, termed C2A and C2B (or C2AB together) 7, 8 . Syt2 and Syt9 are also involved in evoked synchronous neurotransmitter release for subsets of neurons 9 , while Syt7 mediates asynchronous release 10, 11 . Syt1 interacts with both anionic membranes and SNARE complexes [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . In addition to Syt1, the SNARE complex interacts with complexin (Cpx), a small soluble protein that both activates evoked release and suppresses spontaneous release 24 . Syt1, Cpx, and SNAREs cooperate to activate synchronous release upon action potential arrival in the synaptic terminal 25, 26 and regulate spontaneous release 27, 28 .The previously determined structures of the SNARE-Cpx complex 29 and of the Syt1-SNARE complex 21 , along with functional studies, suggested that each binary interaction is essential for evoked release, but these studies explained neither the cooperativity between Syt1, Cpx, and SNAREs, nor the dominant-negative effect of certain Syt1 C2B domain mutations 30, 31 .
During synaptic transmission, Ca 2+ influx into a presynaptic terminal triggers fusion of neurotransmitter-filled synaptic vesicles with the presynaptic plasma membrane 1, 2 . The SNARE proteins synaptobrevin-2/VAMP2 on the synaptic vesicle and syntaxin-1A and SNAP-25 on the plasma membrane initiate vesicle fusion by forming a trans-SNARE complex before Ca 2+ triggering 3, 4 . In addition to SNAREs, synaptotagmin-1 (Syt1) is vital for Ca 2+ -triggered synaptic vesicle fusion 5, 6 . Syt1 contains a single transmembrane-spanning domain and two C-terminal cytoplasmic C2 domains, termed C2A and C2B (or C2AB together) 7, 8 . Syt2 and Syt9 are also involved in evoked synchronous neurotransmitter release for subsets of neurons 9 , while Syt7 mediates asynchronous release 10, 11 . Syt1 interacts with both anionic membranes and SNARE complexes [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . In addition to Syt1, the SNARE complex interacts with complexin (Cpx), a small soluble protein that both activates evoked release and suppresses spontaneous release 24 . Syt1, Cpx, and SNAREs cooperate to activate synchronous release upon action potential arrival in the synaptic terminal 25, 26 and regulate spontaneous release 27, 28 .The previously determined structures of the SNARE-Cpx complex 29 and of the Syt1-SNARE complex 21 , along with functional studies, suggested that each binary interaction is essential for evoked release, but these studies explained neither the cooperativity between Syt1, Cpx, and SNAREs, nor the dominant-negative effect of certain Syt1 C2B domain mutations 30, 31 .
Pre-fusion complex of SNAREs, Cpx, and Syt1
We designed a soluble trans-SNARE complex mimetic suitable for structural studies by truncating the C-terminal end of the synaptobrevin-2 SNARE motif two layers past the central ionic zero layer, thus preventing full zippering of the SNARE complex (Fig. 1a) . We co-crystallized this trans-SNARE complex mimetic with a Syt1 C2AB fragment (or with separate C2A, C2B domains) and a Cpx fragment that was fully active in evoked release (amino acids 1-83) to capture the primed pre-fusion state. Crystal structures of these complexes were determined in two different crystal forms to 1.85 Å resolution (co-crystallized with the C2AB fragment, referred to as Syt1-SNARE-Cpx-Syt1 C2AB crystal structure) and 2.5 Å resolution (co-crystallized with both individual C2A, C2B domains, referred to as Syt1-SNARE-Cpx-Syt1 C2B crystal structure) ( Fig. 1 and Extended Data Table 1) .
By design, the C-terminal ends of the syntaxin-1A and SNAP-25 components are partly unstructured in the absence of the C-terminal residues of the synaptobrevin-2 SNARE motif (Fig. 1a, b, d and Extended Data Fig. 1a, b) . With the exception of the unstructured C-terminal region, the structure of the truncated SNARE complex superimposes well on the structure of the fully assembled SNARE complex 32 (Protein Data Bank (PDB) accession number 1N7S, rootmean-square difference (r.m.s.d.) = 0.63 Å).
The SNARE-Cpx-Syt1 tripartite interface
Both crystal structures contain the previously identified 'primary' interface between Syt1 C2B and the SNARE complex 21 ( Fig. 1 and Supplementary Video 1), illustrating structural conservation in different molecular packing environments (r.m.s.d. = 0.39 Å; Extended Data Fig. 1e, f) . More importantly, the new structures reveal a novel tripartite interface between a second C2B domain, the SNARE complex, and the Cpx central α -helix (Fig. 1b-d and Supplementary Video 1) (referred to as the SNARE-Cpx-Syt1 tripartite interface). The tripartite interface is very similar in both crystal forms (r.m.s.d. = 0.30 Å) (Fig. 1b, d and Extended Data Fig. 1a, b) .
The interactions between the Cpx central α -helix and the SNARE complex are similar to those found in the SNARE-Cpx subcomplex 29, 33, 34 . The Syt1 C2B domain of the tripartite interface binds to this SNARE-Cpx subcomplex by forming a large interface (interface area 990 Å 2 ) with both the SNARE and Cpx components ( Fig. 1b-e) . Strikingly, the α -helix HA of the Syt1 C2B domain extends the Cpx central α -helix (Fig. 1b-f ) and, together with the short 3 10 helix T3 of the Syt1 C2B domain and the SNARE complex, forms a six-helix bundle (Fig. 1c, e) . The HA helix is structurally conserved in known structures of C2B domains of all synaptotagmins, Doc2 and rabphilin3A, but is absent from synaptotagmin C2A domains or Munc13 C2 domains (Extended Data Fig. 2d ).
The tripartite interface does not involve Ca 2+ binding sites, implying Ca 2+ -independent binding. The residues involved in either the SNARECpx-Syt1 tripartite or the Syt1-SNARE primary interfaces have relatively low temperature B-factors, among the lowest in these structures (Extended Data Fig. 1c, d ), suggesting genuine stable interactions.
The tripartite interface is specific
There is excellent shape complementarity between the molecules involved in the SNARE-Cpx-Syt1 tripartite interface (Fig. 2, Extended  Data Fig. 2a, b and Supplementary Video 1). In addition, specificity is conferred by hydrogen bonds and salt bridges between the C-terminal end of the Cpx central α -helix and the N termini of the Syt1 C2B HA and syntaxin-1A SNARE motif helices (Fig. 2a, b) , and by a large hydrophobic interface (Fig. 2c, d ). Primary sequence alignments show that residues that are involved in specific sidechain interactions are highly conserved in Syt1, 2, and 9, that is, isoforms that are involved in fast evoked release (Extended Data Fig. 2c ). There are several ordered water molecules at the periphery of the interface between the Syt1 C2B domain and the SNARE-Cpx subcomplex (Fig. 2a, b) , and a few that are involved in contacts between Syt1 C2B and syntaxin-1A (Extended Data Fig. 2a) . Consequently, the buried interface area of the tripartite interface is largely independent of all ordered water molecules.
A large hydrophobic interface connects the Syt1 C2B domain (including the C-terminal end of α -helix HA and the short 3 10 helix T3) to syntaxin-1A (Fig. 2c) . Several residues of this interface participate in three hydrophobic layers of the above-mentioned six-helix bundle (Fig. 1c, e) . In particular, Syt1 residues Leu394 and I352 form a hydrophobic coiled-coil-like interaction with syntaxin-1A residue Ile203 (Fig. 2d) . In addition, α -helix HB of C2B and the loop between β 8 and HB also interact with Cpx (Extended Data Fig. 2b ).
Specific mutations disrupt the tripartite interface
To test the functional significance of the SNARE-Cpx-Syt1 tripartite interface, we designed two sets of mutations. The L387Q/L394Q mutations (referred to as LLQQ mutant) were chosen to disrupt the hydrophobic interaction that is an integral part of the interface between α -helix HA of Syt1 C2B and the SNARE complex, while the T383Q/G384Q mutations (referred to as TGQQ mutant) were chosen to disrupt interactions at the periphery of the interface (Fig. 2 and Supplementary Video 2). We also tested potential interactions that involve the polybasic region of Syt1 C2B by mutating two Lys residues (K326A/K327A, referred to as KA mutant) to disrupt any dynamic binding modes involving the highly charged polybasic region 20, 22 . All mutants of the Syt1 C2B domain are properly folded (Fig. 2, Extended Data Fig. 3 and Methods). Additionally, we used the quintuple mutations of the primary interface in the Syt1 C2B domain (R281A/E295A/Y338W/R398A/R399A, referred to as C2B Q or quintuple mutant) and the SNARE complex (SNAP-25 K40A/ D51A/E52A/E55A/D166A, referred to as SNARE Q mutant) to selectively disrupt the Syt1-SNARE primary interface and to study the tripartite interaction without the background of the primary interface 21 . We performed isothermal titration calorimetry (ITC) experiments to characterize the effect of these mutations on the various molecular interactions in solution in the absence of Ca 2+ ( Fig. 3 and Extended Data Fig. 4) . Injection of the wild-type (WT) Syt1 C2B domain into a cell containing the WT SNARE complex produced an endothermic heat trace (Fig. 3a, b and Extended Data Fig. 4a ). The quintuple mutation of 21 . For clarity, we omit the C2A domain of the Syt1 molecule involved in the primary interface (Extended Data Fig. 1c) . the primary interface in the SNARE complex and the Syt1 C2B domain did not abolish binding (Fig. 3a, b and Extended Data Fig. 4b-d) , suggesting that multiple interactions between the Syt1 C2B domain and the SNARE complex occur in solution (Extended Data Fig. 5 ). The KA mutant of the Syt1 C2B domain (C2B KA ) produced an exothermic heat of injection trace that could be well fitted to a first-order reaction (Fig. 3a, b and Extended Data Fig. 4e ). Upon additional mutation of the primary interface, little binding was observed between Syt1 C2B KA and the SNARE Q complex, and between Syt1 C2B KA-Q and the SNARE complex (Fig. 3a, b and Extended Data Fig. 4f, g ), suggesting that the only significant interactions in solution in the absence of Ca 2+ are the primary Syt1-SNARE interaction 21 and promiscuous interactions involving the polybasic interface of Syt1 C2B (Extended Data  Fig. 5 ). Although each of these individual interactions with the polybasic region may be considerably weaker than the primary interface, collectively they will dominate the overall ITC binding trace, obscuring the specific binding signal. In the presence of anionic phospholipid membranes, the membrane interactions stabilize the Syt1-SNARE primary interface 21 , lowering the dissociation constant, K d , to 0.9 μ M (ref. 23) . Moreover, the localization of Syt1 to the same membrane as synaptobrevin may further lower the dissociation constant in the physiological context.
To test the SNARE-Cpx-Syt1 tripartite interface in solution, we combined the quintuple mutants of the primary interface and the KA mutant of the polybasic region (Syt C2B KA-Q , SNARE Q ) since these combined mutations disrupt the Syt1-SNARE primary interface and the weak interactions involving the polybasic region of the Syt1 C2B domain, resulting in total loss of SNARE binding to the Syt1 C2B domain in the absence of Cpx (Fig. 3c, d 
Evoked release requires the tripartite interface
To determine the physiological role of the SNARE-Cpx-Syt1 tripartite interface in neurons, WT Syt1, and its TGQQ and LLQQ mutants were separately expressed in cultured cortical neurons derived from double-mutant mice harbouring Syt1 conditional and Syt7 constitutive knockout (KO) alleles 21, 30 . Consistent with a previous report 11 , Syt7 KO neurons maintained normal synchronous synaptic release, while double removal of Syt1/7 suppressed synchronous and asynchronous release and increased spontaneous mini-release, as indicated by the decreased amplitude of evoked inhibitory postsynaptic currents (IPSCs; Fig. 4a ) and the increased frequency of miniature IPSCs (mIPSCs; Extended Data Fig. 6b ). These phenotypes could be fully rescued by expression of WT Syt1 (Syt1 WT ) or TGQQ mutant Syt1, but not by LLQQ mutant Syt1 ( Fig. 4a and Extended Data Fig. 6a, b) , consistent with our ITC binding studies that showed that the LLQQ mutant, but not the TGQQ mutant, abolishes the tripartite interface (Fig. 3) . Therefore, the tripartite interface plays an indispensable role in synaptic release. Besides LLQQ, the quintuple mutant (Syt1 Quintuple ), which disrupts the Syt1-SNARE primary interface, also failed to rescue synaptic release ( Fig. 4a and Extended Data Fig. 6a, b) , as previously reported 21 . Taken together, our results indicate that Syt1-mediated Ca 2+ triggering of evoked synchronous release and inhibition of spontaneous release commonly require both the primary and tripartite interfaces.
Role of Ca 2+ binding for interface function
To further test the physiological significance of the primary and tripartite interfaces, we recorded synaptic responses in cultured WT cortical neurons, with expression of either exogenous WT or D309A/D363A/D365A-mutant (Syt1 DA ) Syt1. Syt1 DA abolishes Ca 2+ -dependent liposome binding to the Syt1 C2B domain 35 , and expression of Syt1 DA in WT neurons blocks both endogenous Syt1 and Syt7 function, thus suppressing evoked neurotransmitter release 30 ( Fig. 4b, c) and prompting us to examine whether Syt1 DA is dominant-negative for release by locking the SNARE-Cpx-Syt1 tripartite complex into place. We tested the effect of the additional TGQQ, LLQQ, and quintuple mutations on the dominant-negative activity of Syt1 DA (Fig. 2) . While Syt1 WT in cultured WT neurons induced no phenotype, Syt1 DA expression, as expected, reduced the amplitudes of both evoked IPSCs (Fig. 4b ) and evoked excitatory postsynaptic currents (EPSCs; Fig. 4c) , and increased the frequencies of both mIPSCs (Extended Data Fig. 6d ) and miniature EPSCs (mEPSCs; Extended Data Fig. 6e) .
Remarkably, the dominant-negative activity of Syt1 DA was eliminated by the LLQQ mutant but not by the TGQQ mutant (Fig. 4b, c and Extended Data Fig. 6c-e) , indicating the importance of the tripartite interface for the Syt1 DA dominant-negative phenotypes. Conversely, the Syt1
Quintuple mutation of the primary interface had no effect on the Syt1 DA phenotype (Fig. 4b, c and Extended Data Fig. 6c-e) , indicating that the Syt1-SNARE primary interface is not involved in producing the dominant-negative effect of Syt1 DA . Inhibition of spontaneous release by Syt1 depended on both the tripartite and primary interfaces (Extended Data Fig. 6d, e) : that is, elimination of either interface resulted in an increase in mini frequency. The increased mini-release in Syt1-deficient neurons is mediated by another Ca 2+ sensor with a lower Ca 2+ cooperativity than typically observed with synaptotagmins 26 . Consistent with this observation, we found that the increased mini-release induced by dominantnegative Syt1
DA expression and measured as mIPSCs was blocked by the LLQQ mutations and by the intracellular Ca 2+ chelator BAPTA-AM (Extended Data Fig. 7 ).
The role of Cpx in the tripartite interface
The LLQQ mutant prevented the control of synaptic release by Syt1 (Fig. 4a-c) . However, the LLQQ mutant only probed the interaction between α -helix HA of Syt1 C2B and the SNARE complex. To further probe the role of Cpx in the SNARE-Cpx-Syt1 tripartite interface, we asked whether complexin is required for the dominant-negative lock imposed on release by mutant Syt1 DA . We combined exogenous Syt1 expression with Cpx1/2 double knockdown (DKD) in WT neurons as previously described 25, 36 . Again, compared with Syt1 WT , exogenous Syt1 DA expression without Cpx1/2 DKD severely suppressed the amplitude of IPSCs (Fig. 4d) and EPSCs (Fig. 4e) , and increased the frequency of mIPSCs (Extended Data Fig. 6g ) and mEPSCs (Extended Data Fig. 6h) .
In WT neurons with exogenous Syt1 WT expression, the Cpx1/2 DKD partly decreased the evoked IPSC and EPSC amplitudes, and increased mIPSC and mEPSC frequencies (Fig. 4d, e and Extended Data Fig. 6f-h ) 25 . However, in WT neurons with exogenous Syt1 DA expression, the Cpx1/2 DKD partly reversed the massive dominantnegative effect of Syt1 DA . As a result, synaptic responses in Cpx1/2 DKD neurons were identical in neurons with Syt1
WT and Syt1 DA expression. Considering that the effect of Cpx1/2 DKD is milder than the effect of expression of Syt1 DA , this result cannot be explained by saturation due to over expression. Rather, the dominant-negative effect of the Syt1 DA mutant requires Cpx, consis tent with the tripartite interface observed in our crystal structures. The Cpx1/2 DKD is expected to greatly reduce SNARE-Cpx-Syt1 tripartite complexes, and, in turn, to reduce the effect of the dominant-negative Syt1 DA mutant. Interestingly, the pheno types of expression of Syt1
WT or Syt DA with Cpx1/2 DKD are not as severe as the Cpx1/2 DKD alone 25 , suggesting that both exogenously expressed Syt1
WT or Syt DA in WT neurons can partly compensate for the Cpx deletion.
The readily releasable pool requires both interfaces
We measured the presynaptic readily releasable pool of synaptic vesicles, thought to correspond to vesicles primed in a pre-fusion state, in cultured cortical neurons by monitoring IPSCs induced by hypertonic sucrose, which stimulates Ca 2+ -independent exocytosis of all primed synaptic vesicles 30 . Consistent with earlier studies 30 , Syt7 KO neurons maintained normal sucrose-induced release, while double removal of Syt1/7 induced an ~ 60% decrease (Fig. 5a) (Fig. 5a ). Thus, both the primary and tripartite interfaces are, surprisingly, required for supporting the Data Fig. 6a , c, f. Shown are means ± s.e.m.; the numbers of neurons/independent cultures are indicated. Statistical significance was assessed by Student's t-test (* * P < 0.01; * * * P < 0.001; NS, no significant difference) with respect to either the Cre (red) or the Cre + Syt1 group (black) in a, either the control (black) or the Syt1 DA group (red) in b and c, and between Syt1
WT and Syt1 DA with or without Cpx1/2 DKD in d and e.
Article reSeArcH readily releasable pool, suggesting that both are required for fusion competence.
Discussion
Two Syt1 molecules simultaneously interact with two binding interfaces on opposite sides of the SNARE complex: the SNARE-Cpx-Syt1 tripartite interface discovered here and the previously described primary interface (Fig. 1) . Both binding interfaces are essential for Ca 2+ -triggered neurotransmitter release (Figs 3 and 4) : when the tripartite interface is disrupted while the primary interface is intact, or vice versa, little evoked release occurs (Fig. 4a) , suggesting that both the primary and tripartite interfaces are required for Ca 2+ -triggered synaptic vesicle fusion. The functional role of the two interfaces, however, is different.
The Syt1-SNARE primary interface is specific for fast Ca 2+ sensors (Syt1, Syt2, Syt9) 9, 21 . In contrast, the newly discovered tripartite interface may be a more general interface involving other synaptotagmins, given the sequence conservation of the T3 and HA helices (Fig. 1e ) among all synaptotagmin C2B domains (Extended Data Fig. 2d ). Different types of synaptotagmin-regulated exocytosis are mediated by similar Cpx-dependent fusion mechanisms 9, [37] [38] [39] , so it is conceivable that these other synaptotagmins could participate in a tripartite interface.
The tripartite interface involves the central α -helix, but not the accessory helix of Cpx or any other part of Cpx (Fig. 1b and Extended Data Fig. 8a-c) . Previous in vitro fusion experiments showed that the accessory domain can be entirely eliminated while maintaining the activating function of Cpx: that is, the N-terminal and central domains of Cpx can be reconstituted as separate fragments 40 . Our Syt1-SNARECpx-Syt1 structures now explain the functional requirement of the central α -helix of Cpx since it is an integral part of the tripartite interface, while the Cpx N-terminal domain can independently interact with the splayed-open trans-SNARE complex 41 . We propose that the structure of the Syt1-SNARE-Cpx-Syt1 complex is the pre-fusion state of the complex (Fig. 5b, c) . The tripartite interface at the same time activates and 'locks' the complex, keeping the energized trans-SNARE complex half zippered and the membranes apart, thereby preventing membrane fusion (Fig. 5d) . Consistent with this model of the primed state, constitutive insertion of Cpx into the SNARE complex locks release 42 , and inclusion of Cpx increases the separation between membranes in a reconstituted system as observed by electron cryo-tomography 43 . The Ca 2+ binding loops of the C2 domains in the crystal structures of the primed complex are not involved in the primary and tripartite interfaces. Upon Ca 2+ binding to the C2 domains of the primed complex, we propose that the tripartite interface is unlocked, allowing Ca 2+ -triggered fusion to proceed. Upon Ca 2+ binding, the Syt1 molecule that is involved in the tripartite interface probably triggers a cascade of molecular rearrangements, including dissolution of the tripartite interface ( Fig. 5e ) with possible liberation of Cpx 42 . In the crystal structure, the Syt1 C2A domain of the tripartite complex is close to the Cpx core helix and the C terminus of the synaptobrevin-2 SNARE motif (Fig. 5d) , and is flexibly linked to the C2B domain (Extended Data Fig. 8d) . Thus, the C2A domain might cooperate with the C2B domain in either process, consistent with importance of the Ca 2+ binding sites of both the C2A and C2B domains in neurotransmitter release 26 . There are probably two or more synaptic complexes involved in Ca 2+ -triggered fusion that could potentially interact with each other. For example, one Syt1 C2B domain could bridge two SNARE complexes via the primary and tripartite interfaces (Extended Data Fig. 9) . Moreover, the presence of the membranes will probably affect the conformation of the pre-fusion complex. Upon unlocking the primed complex, the trans-SNARE complex will fully zipper up and trigger fusion, possibly in conjunction with Ca 2+ -dependent membranebending action of all C2A and C2B domains-including those of the primary interface-as previously proposed 21 (Fig. 5e ). The Syt1-SNARE-Cpx-Syt1 structure explains why the Cpx DKD or double knockout (DKO), and the Syt1 KO, impair Ca 2+ -evoked release, since the primed state of the system cannot form. Similarly, if the Syt1 DA mutant is bound to a particular complex, the complex is primed, but the Syt1 DA mutant is unable to unlock the complex. When some of the tripartite interfaces that participate in a docked synaptic vesicle remain locked, triggered fusion cannot occur, which explains the dominant-negative phenotype of the Syt1 DA mutant. Taken together, we thus propose an atomic model that accounts for vesicle priming and the cooperation between Cpx, Syt1, and SNAREs in synchronizing and activating evoked release on the sub-millisecond timescale.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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No statistical methods were used to predetermine sample size. No formal randomization process was used for all experiments. Investigators in the experiments described in Figs 4 and 5a and Extended Data Figs 6 and 8 were blinded to allocation and outcome assessments; all other experiments were not randomized and investigators were not blinded. All statistical tests are two-sided. All animal experiments were evaluated and approved by the Stanford University Administrative Panel on Laboratory Animal Care. Expression and purification of recombinant proteins. For the trans-SNARE complex mimetic used in the crystallizations, the decimal-histidine-tagged and C-terminally truncated rat synaptobrevin-2 fragment (amino-acid range 28-66), the rat syntaxin-1A fragment (amino-acid range 191-256), the rat SNAP-25_N fragment (amino-acid range 7-83), and the rat SNAP-25_C fragment (amino-acid range 191-256) were cloned into the Duet expression system (Novagen) following previous work with the neuronal SNARE complex 44 (Fig. 1a) . These four protein constructs were co-expressed in Escherichia coli, leading to complex formation in the host (referred to as the trans-SNARE complex mimetic). Specifically, E. coli BL21(DE3) were grown overnight at 37 °C using auto-inducing LB medium 45 . After harvesting the cells by centrifugation, the pellet was re-suspended in lysis buffer (50 mM Tris-HCl, pH 8.0, 300 mM NaCl, 20 mM imidazole, 0.5 mM TCEP) and subjected to sonication and centrifugation. The cleared lysate was bound to Ni-NTA agarose beads (Qiagen) equilibrated in the lysis buffer. Beads were harvested by centrifugation and poured into a column, washed with the lysis buffer, urea buffer (50 mM Tris-HCl, pH 8.0, 300 mM NaCl, 60 mM imidazole, 0.5 mM TCEP, 7.5 M urea), and wash buffer (50 mM Tris-HCl, pH 8.0, 300 mM NaCl, 60 mM imidazole, 0.5 mM TCEP). The trans-SNARE complex mimetic was eluted with the lysis buffer supplemented with additional 330 mM imidazole. The fresh eluent of the Ni-NTA affinity purified trans-SNARE complex mimetic was supplemented with tobacco etch virus protease and dialysed against buffer A1 (50 mM Tris-HCl, pH 8.0, 50 mM NaCl, 0.5 mM TCEP, 1 mM EDTA) overnight at 4 °C. After removal of uncleaved sample, the His-tag-free complex was subjected to anion exchange chromatography (buffer A1: 50 mM Tris-HCl, pH 8.0, 50 mM NaCl, 0.5 mM TCEP, 1 mM EDTA; buffer B1: 50 mM Tris-HCl, pH 8.0, 500 mM NaCl, 0.5 mM TCEP, 1 mM EDTA) using a linear gradient of NaCl starting at 50 mM and ending at 500 mM. The peak was eluted at ~ 250 mM NaCl. The peak fractions were pooled and concentrated to a final concentration of ~ 1 mM and stored at − 80 °C for crystallization.
For the SNARE complex used for circular dichroism and ITC experiments, the decimal-histidine-tagged rat synaptobrevin-2 fragment (amino-acid range 28-89), the rat syntaxin-1A fragment (amino-acid range 191-256), the rat SNAP-25_N fragment (amino-acid range 7-83), and the rat SNAP-25_C fragment (aminoacid range 191-256), as well as the quintuple mutation of the SNARE complex (SNAP-25 K40A, D51A, E52A, E55A, D166A, referred to as SNARE Q ), were cloned, expressed, and purified similarly to the trans-SNARE complex mimetic.
The rat complexin-1 fragment (amino-acid range 1-83) was cloned into the pGEX-6P-1 vector and expressed in E. coli BL21(DE3) cells at 37 °C overnight using auto-inducing LB medium 45 . After harvesting the cells by centrifugation, the pellet was re-suspended in lysis buffer (50 mM HEPES, pH 7.5, 300 mM NaCl, 0.5 mM TCEP, 1 mM EDTA) and subjected to sonication and centrifugation. The cleared lysate was bound to glutathione-sepharose beads (GE Healthcare) equilibrated in the lysis buffer. The resin was harvested by centrifugation and poured into a column, extensively washed with the lysis buffer, and subsequently washed with the lysis buffer and wash buffer (50 mM HEPES, pH 7.5, 1 M NaCl, 0.5 mM TCEP, 1 mM EDTA). The Cpx fragment was cleaved from the GST moiety by PreScission protease in 10 ml lysis buffer at 4 °C overnight. The protein was eluted from the glutathione-sepharose resin with lysis buffer, then concentrated and loaded onto a Superdex 75 10/300 GL column (GE Healthcare) that was pre-equilibrated with SEC buffer (25 mM HEPES, pH 7.5, 300 mM NaCl, 0.5 mM TCEP, 1 mM EDTA). The peak fractions were pooled, concentrated, and stored at − 80 °C.
The rat complexin-1 central α -helix fragment (amino-acid range 48-73) was cloned and expressed similarly to the longer Cpx(1-83) fragment. However, it was difficult to concentrate Cpx central α -helix fragment to high concentration. Therefore, the cleaved protein was eluted from the resin with buffer A2 (50 mM MES, pH 6.2, 50 mM NaCl, 0.5 mM TCEP, 1 mM EDTA), then purified by cation exchange chromatography on a MonoS column (GE Healthcare) in buffer A2 using a linear gradient from 50 mM to 500 mM NaCl. The peak fractions were pooled and stored at − 80 °C.
The rat Syt1 C2AB fragment (amino-acid range 140-421), C2A domain (amino-acid range 140-263), C2B domain (amino-acid range 271-421), and mutant Syt1 C2B domains were cloned into the pGEX-6P-1 vector and expressed as GST-tagged fusion proteins in E. coli BL21(DE3) cells at 37 °C for 3-4 h first, then decreased to 25 °C overnight using auto-inducing LB medium 45 . After harvesting the cells by centrifugation, the sample was re-suspended in lysis buffer (50 mM HEPES, pH 7.5, 300 mM NaCl, 0.5 mM TCEP, 1 mM EDTA) and subjected to sonication and centrifugation. The supernatant was incubated to glutathione-sepharose beads equilibrated in the lysis buffer. The resin was extensively washed with the lysis buffer, and subsequently washed with the lysis buffer, CaCl 2 buffer (50 mM HEPES, pH 7.5, 1 M NaCl, 0.5 mM TCEP, 50 mM CaCl 2 ), and wash buffer (50 mM HEPES, pH 7.5, 1 M NaCl, 0.5 mM TCEP, 1 mM EDTA). The Syt1 fragments were cleaved from the GST moiety by PreScission protease in 10 ml lysis buffer at 4 °C overnight. The protein was eluted from the resin with lysis buffer. For the Syt1 C2A domain, Syt1 C2B
KA-Q mutant, Syt1 C2B KA-Q-TGQQ mutant, and Syt1 C2B
KA-Q-LLQQ mutant, the fresh eluent was concentrated and loaded onto a Superdex 75 10/300 GL column pre-equilibrated with SEC buffer (25 mM HEPES, pH 7.5, 300 mM NaCl, 0.5 mM TCEP, 1 mM EDTA). The peak fractions were pooled and concentrated. For other proteins, the fresh eluent was dialysed in buffer A2 at 4 °C for 3-4 h and purified by cation exchange chromato graphy on a MonoS column in buffer A2 using a linear gradient from 50 to 500 mM NaCl. The peak fractions were pooled and stored at − 80 °C. Crystallization, data collection, and structure solution. Before setting up crystal trays, the trans-SNARE complex mimetic, Cpx(1-83), and Syt1 C2AB fragment (or both Syt1 C2A and C2B domain fragments) were mixed to obtain a molar ratio of 1:1.2:1.5 and dialysed in crystallization final buffer (25 mM Tris-HCl, pH 8.0, 150 mM NaCl, 50 mM MgCl 2 , 0.5 mM TCEP) at 4 °C overnight. Crystals were grown by the hanging-drop vapour diffusion method at 20 °C by mixing 2 μ l protein solution with an equal volume of reservoir solution. Note that the concentration of the trans-SNARE complex mimetic in protein solution was 100-200 μ M. For the Syt1-SNARE-Cpx-Syt1 C2AB crystals, the reservoir contained 100 mM HEPES, pH 7.4, 15-20% PEG3350, 200 mM ammonium formate. For the Syt1-SNARE-Cpx-Syt1 C2B crystals (co-crystallized with both Syt1 C2A and C2B domain fragments), the reservoir contained 100 mM HEPES, pH 7.0, 15-17% PEG3350, 240 mM sodium malonate. Both crystals were flashfrozen in a cryo-protecting solution containing the same constituents as the crystallization condition supplemented with 20% (v/v) glycerol.
Both diffraction data sets (Extended Data Table 1 ) were collected at beamline 24ID-C of the Advanced Photon Source at Argonne National Laboratory (Argonne, Illinois, USA). Diffraction data of the best crystals of both the Syt1-SNARE-Cpx-Syt1 C2AB complex and the Syt1-SNARE-Cpx-Syt1 C2B complex were indexed and integrated using the XDS software 46 , and scaled and merged using the SCALA program in the CCP4 package 47 . The phases for both crystal forms were determined by molecular replacement with Phaser 48 using the SNARE-Cpx complex (PDB accession number 1KIL), the rat Syt1 C2A domain (PDB accession number 3F04), and the rat Syt1 C2B domain (PDB accession number 1UOW) as search models. The asymmetric unit consists of one SNARE-Cpx complex and one C2AB fragment for the Syt1-SNARE-Cpx-Syt1 C2AB crystal structure, and of one SNARE-Cpx complex and one C2B domain for the Syt1-SNARE-Cpx-Syt1 C2B crystal structure. We did not observe electron density for the Syt1 C2A domain in the Syt1-SNARE-Cpx-Syt1 C2B crystal structure even though it was included in the crystallization condition as a separate fragment. Moreover, the electron density of the C2A domain in the Syt1-SNARE-Cpx-Syt1 C2AB crystal structure is relatively weak, resulting in high B-factors (Extended Data Fig. 1c ) and suggesting conformational variability of the C2A domain. The N terminus of Cpx and the C terminus of the SNARE complex also exhibit relatively high B-factors in both structures. The structures were iteratively rebuilt and refined using the programs Coot 49 and phenix.refine 50 (Extended Data Table 1 ). Ramachandran analysis with MolProbity 51 indicated that 96% (Syt1-SNARE-Cpx-Syt1 C2AB crystal structure) and 98% (Syt1-SNARECpx-Syt1 C2B crystal structure) of the residues are in the favoured regions and none are in disallowed regions. Validation and structure analysis. MolProbity 51 was used to evaluate the geometry and quality of the models (Extended Data Table 1 ). All structure figures were prepared with PyMol (http://www.pymol.org). Interface areas were calculated by PISA 52 ; note that the commonly used 'buried surface area' is twice the 'interface area' . Circular dichroism spectroscopy. Circular dichroism measurements were conducted with circular dichroism spectrometer Model 202-01 (Aviv Biomedical) equipped with a temperature controller. Data were collected with 10 μ M samples of WT and mutant Syt1 C2B proteins, the SNARE complex, as well as the SNARE Q complex mutant in 10 mM Tris-HCl (pH 8.0), 100 mM NaCl buffer (with 5 mM EGTA or 5 mM CaCl 2 ) over a wavelength range of 200-260 nm, with 1 nm increments, in a 1 mm path length cell at 25 °C. Temperature denaturation experiments were performed at a wavelength of 216 nm (for C2B and its mutants) or 220 nm (for the SNARE complexes) by increasing the temperature from 25 to 100 °C in 3 °C temperature increments, a 2 min temperature equilibration time, and a 3 s averaging time. The fraction of unfolded protein at each temperature was calculated by using the formula (I obs − I f )/(I u − I f ), where I obs is the observed mean residue ellipticity, and I u and I f are the mean residue ellipticities of the unfolded and folded states, respectively. I u and I f were estimated by extrapolation of the linear regions of the extremes of the denaturation curves. ITC. We tested different buffer compositions and protein concentrations for ITC experiments on an ITC200 microcalorimeter (Microcal, GE Healthcare). The best results were obtained when the NaCl concentration was 100 mM and the protein concentration in the sample cell was higher than 50 μ M. These conditions were used for all following ITC experiments. We used the Cpx central α -helix Cpx in the ITC experiments since it corresponded to the structured part of Cpx in our crystal structures.
Final ITC measurements (shown in Fig. 3 and Extended Data Fig. 4 ) were performed on a VP-ITC calorimeter (Microcal, GE Healthcare) at 25 °C. All protein samples were dialysed against a buffer solution containing 10 mM HEPES (pH 7.4), 100 mM NaCl, and 0.5 mM TCEP three times for 3 h, 5 h, and overnight. The final buffer was used as washing buffer for the ITC instrument. Samples were degassed for 10 min before the experiment. The SNARE or SNARE Q complex or SNARE/Cpx Fig. 4j ): that is, the tripartite interface is independent of the presence of the quintuple mutations in the C2B domain. Data were analysed with the AFFINImeter and Origin ITC software supplied by the instrument's manufacturer.
We note that both endothermic and exothermic interactions are often observed for protein-protein interfaces and protein-ligand interactions [53] [54] [55] . Neuronal cultures. Cortical neurons were cultured from newborn male and female mice for all electrophysiology experiments as previously described 56 . Briefly, mouse cortices were dissected from postnatal day 1 (P1) of Syt1 cKO/ Syt7 KO 21, 30 or WT CD-1 mice, dissociated by papain digestion (10 U ml −1 ) for 20 min at 37 °C, plated on Matrigel-coated circular glass coverslips (12 mm diameter), and cultured in MEM (Gibco) supplemented with 2 mM glutamine (Gibco), 0.4% w/v glucose (Sigma), 2% B-27 (Gemini), and 5% fetal bovine serum (Atlanta Biological). At 1 day in vitro the culture media were changed to Neurobasal-A (Gibco) supplemented with 2 mM glutamine, 2% B-27, and 5% serum, with 2 μ M Ara-C (Sigma) added at 3 days in vitro. Neurons were infected with lentiviruses at 3-4 days in vitro, and analysed at 13-16 days in vitro. Plasmid construction. We used the same lentiviral construct as previously described 21 carrying a synapsin promoter, an optional rat Syt1 cDNA, internal ribosome entry site, and a green fluorescent protein (GFP)-Cre recombinase fusion sequence. The control plasmid contained no cDNA, with plasmids carrying the following cDNAs: WT, TGQQ (T383Q/G384Q), LLQQ (L387Q/L394Q), quintuple (R281A/E295A/Y338W/R398A/R399A), DA (D309A/D363A/D365A), DA and TGQQ, DA and LLQQ, DA and quintuple.
The complexin1/2 DKD construct was described previously 25 . Lentiviruses production. Lentiviral expression vectors and three helper plasmids (pRSV-REV, pMDLg/pRRE, and pVSVG) were co-transfected into HEK293T cells (American Type Culture Collection, Virginia), at 6, 2, 2, and 2 μ g of DNA per 25 cm 2 culture area, respectively 57 , by using calcium phosphate. Cell-culture supernatants containing the viruses were collected 48 h after transfection and directly used for infection of neurons. All steps were performed under level II biosafety conditions. Electrophysiological recordings. Recordings were performed in whole-cell patch-clamp mode using concentric extracellular stimulation electrodes 58 . Evoked synaptic responses were triggered by a bipolar electrode placed 100-150 μ m from the soma of neurons recorded. Patch pipettes were pulled from borosilicate glass capillary tubes (Warner Instruments) using a PC-10 pipette puller (Narishige). The resistance of pipettes filled with intracellular solution varied between 2 and 3 MΩ . After formation of the whole-cell configuration and equilibration of the intracellular pipette solution, the series resistance was adjusted to 8-12 MΩ . Synaptic currents were monitored with a Multiclamp 700B amplifier (Molecular Devices). The frequency, duration, and magnitude of the extracellular stimulus were controlled with a Model 2100 Isolated Pulse Stimulator (A-M Systems) and synchronized with Clampex 9 data acquisition software (Molecular Devices). The whole-cell pipette solution contained (in mM) 120 CsCl, 5 NaCl, 1 MgCl 2 , 10 HEPES, 10 EGTA, 0.3 Na-GTP, 3 Mg-ATP, and 5 QX-314 (pH 7.2, adjusted with CsOH). The bath solution contained (in mM) 140 NaCl, 5 KCl, 2 MgCl 2 , 2 CaCl 2 , 10 HEPES, and 10 glucose (pH 7.4, adjusted with NaOH). IPSCs and EPSCs were pharmacologically isolated by adding the AMPA (α -amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) and NMDA (N-methyl-d-aspartate) receptor blockers CNQX (10 μ M) and AP-5 (50 μ M), or the GABA A (γ -aminobutyric acid)-receptor blocker picrotoxin (100 μ M) with AP-5 (50 μ M), to the extracellular solution. Spontaneous mIPSCs and mEPSCs were monitored in the presence of tetrodotoxin (1 μ M) to block action potentials. Miniature events were analysed in Clampfit 9 (Molecular Devices) using the template matching search and a minimal threshold of 5 pA, and each event was visually inspected for inclusion or rejection by an experimenter blind to the recording condition. Sucrose-evoked release was triggered by a 30-s application of 0.5 M sucrose in the presence of AP-5, CNQX, and TTX, puffed by Picospritzer III (Parker). Data availability. The coordinates of the atomic models and corresponding structure factors have been deposited in the PDB under accession numbers 5W5C and 5W5D. All other relevant data are included with the manuscript as source data or Supplementary Videos. The original and/or analysed data sets generated during the current study are available from the corresponding author upon reasonable request.
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Extended Data Figure 1 | Crystal packing and B-factors.  a, b , Views of the crystal lattice of the Syt1-SNARE-Cpx-Syt1 C2AB (a) and Syt1-SNARE-Cpx-Syt1 C2B (b) crystal structures. The red rectangles highlight the C-terminal ends of the SNARE complexes. They are unstructured and form no crystal contacts in either crystal form. c, d, B-factor coloured cartoon representations of the Syt1-SNARE-Cpx-Syt1 C2AB (c) and Syt1-SNARE-Cpx-Syt1 C2B (d) crystal structures (the second Syt1 molecule is related to the first by crystallographic symmetry). Both the primary and tripartite interfaces have low B-factors. e, f, Views of the molecular packing arrangements around the SNARE (coloured) and Syt1 C2B (orange) components that form that primary interface in the Syt1-SNARE-Cpx-Syt1 C2AB crystal structure (e) and the SNARE-Syt1 C2AB crystal structure (f, PDB accession number 5CCH). The molecular packing arrangements around the SNARE and Syt1 C2B components that form that primary interface are vastly different in these crystal structures, illustrating that the formation of the primary interface is entirely independent of crystal packing environments. We also note that the protein constructs and crystallization conditions were very different for these structures.
